FDG-PET in radiotherapy treatment planning of advanced head and neck cancer-A prospective clinical analysis

Auris Nasus Larynx

Volumn 33, Issue 3, 2006, Pages 303-309

  Dietl, Barbara ^a   Marienhagen, Jörg ^a   Kühnel, Thomas ^a   Schaefer, Christof ^a   Kölbl, Oliver ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Diagnostic impact; FDG PET; Head and neck cancer; Radiotherapy treatment planning; Therapeutic impact

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; FLUORODEOXYGLUCOSE; PLATINUM DERIVATIVE;

ADVANCED CANCER; ARTICLE; BONE METASTASIS; BRONCHUS CARCINOID; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MEDIASTINUM LYMPH NODE; MEDICAL INFORMATION; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR;

CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 33745008381     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2006.01.002     Document Type: Article

References (38)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics. CA Cancer J Clin 54 (2004) 8-29
2. Spitz M.R. Epidemiology and risk factors for head and neck cancer. Semin Oncol 21 (1994) 281-288
3. O'Sullivan B., and Shah J. New TNM staging criteria for head and neck tumors. Semin Surg Oncol 21 (2003) 30-42
4. Iro H., and Waldfahrer F. Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients. Cancer 83 (1998) 2201-2207
5. Jones A.S., Morar P., Phillips D.E., Field J.K., Husband D., and Helliwell T.R. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75 (1995) 1343-1353
6. de Vries N., and Snow G.B. Multiple primary tumours in laryngeal cancer. J Laryngol Otol 100 (1986) 915-918
7. McGarry G.W., Mackenzie K., Periasamy P., McGurk F., and Gatehouse S. Multiple primary malignant tumours in patients with head and neck cancer: the implications for follow-up. Clin Otolaryngol 17 (1992) 558-562
8. Ong T.K., Kerawala C.J., Martin I.C., and Stafford F.W. The role of thorax imaging in staging head and neck squamous cell carcinoma. J Craniomaxillofac Surg 27 (1999) 339-344
9. Shah J.P., and Lydiatt W. Treatment of cancer of the head and neck. CA Cancer J Clin 45 (1995) 352-368
10. Fu K.K., Pajak T.F., Trotti A., Jones C.U., Spencer S.A., Phillips T.L., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
11. Pfreundner L., Pahnke J., Desing A., and Schindel M. Systematic analysis of cervical lymph node metastasis of larynx and hypopharynx carcinomas-a clinical computerized tomography study with special reference to extension of the primary tumor. Laryngorhinootologie 75 (1996) 602-610
12. Pfreundner L., Pahnke J., and Wameling S. Analysis of cervical lymph node metastasis of oropharyngeal carcinoma in relation to extent of the primary tumor. Laryngorhinootologie 75 (1996) 223-230
13. Fischbein N.J., AAssar O.S., Caputo G.R., Kaplan M.J., Singer M.I., Price D.C., et al. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck. AJNR Am J Neuroradiol 19 (1998) 1189-1196
14. Liu C.S., Shen Y.Y., Lin C.C., Yen R.F., and Kao C.H. Clinical impact of [(18)F]FDG-PET in patients with suspected recurrent breast cancer based on asymptomatically elevated tumor marker serum levels: a preliminary report. Jpn J Clin Oncol 32 (2002) 244-247
15. Warburg O. On respiratory impairment in cancer cells. Science 124 (1956) 269-270
16. Bernards R. Cancer: cues for migration. Nature 425 (2003) 247-248
17. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36 (2004) 1-12
18. Jung Y.J., Isaacs J.S., Lee S., Trepel J., and Neckers L. IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17 (2003) 2115-2117
19. Wingo P.A., Tong T., and Bolden S. Cancer statistics. CA Cancer J Clin 45 (1995) 8-30
20. Merino O.R., Lindberg R.D., and Fletcher G.H. An analysis of distant metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 40 (1977) 145-151
21. Leon X., Quer M., Orus C., del P.V., and Lopez M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 22 (2000) 680-686
22. Kotwall C., Sako K., Razack M.S., Rao U., Bakamjian V., and Shedd D.P. Metastatic patterns in squamous cell cancer of the head and neck. Am J Surg 154 (1987) 439-442
23. Bhatia R., and Bahadur S. Distant metastasis in malignancies of the head and neck. J Laryngol Otol 101 (1987) 925-928
24. Shingaki S., Saito R., Kawasaki T., and Nakajima T. Adenoid cystic carcinoma of the major and minor salivary glands. A clinicopathological study of 17 cases. J Maxillofac Surg 14 (1986) 53-56
25. Al Othman M.O., Morris C.G., Hinerman R.W., Amdur R.J., and Mendenhall W.M. Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 25 (2003) 629-633
26. de Bree R., Deurloo E.E., Snow G.B., and Leemans C.R. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 110 (2000) 397-401
27. Garden A.S., Asper J.A., Morrison W.H., Schechter N.R., Glisson B.S., Kies M.S., et al. Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?. Cancer 100 (2004) 1171-1178
28. Calhoun K.H., Fulmer P., Weiss R., and Hokanson J.A. Distant metastases from head and neck squamous cell carcinomas. Laryngoscope 104 (1994) 1199-1205
29. Troell R.J., and Terris D.J. Detection of metastases from head and neck cancers. Laryngoscope 105 (1995) 247-250
30. Brizel D.M., Albers M.E., Fisher S.R., Scher R.L., Richtsmeier W.J., Hars V., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338 (1998) 1798-1804
31. Merlano M., Corvo R., Margarino G., Benasso M., Rosso R., Sertoli M.R., et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous cell carcinoma of the head and neck. The final report of a randomized trial. Cancer 67 (1991) 915-921
32. Pignon J.P., Bourhis J., Domenge C., and Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355 (2000) 949-955
33. Rusthoven K.E., Koshy M., and Paulino A.C. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 101 (2004) 2641-2649
34. Stoeckli S.J., Mosna-Firlejczyk K., and Goerres G.W. Lymph node metastasis of squamous cell carcinoma from an unknown primary: impact of positron emission tomography. Eur J Nucl Med Mol Imaging 30 (2003) 411-416
35. Reske SN, Kotzerke J. FDG-PET for clinical use. Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III", 21 July and 19 September 2000. Eur J Nucl Med 2001;28:1707-23.
36. Eichhorn T., Schroeder H.G., Glanz H., and Schwerk W.B. Histologically controlled comparison of palpation and sonography in the diagnosis of cervical lymph node metastases. Laryngol Rhinol Otol (Stuttg) 66 (1987) 266-274
37. Jabour B.A., Choi Y., Hoh C.K., Rege S.D., Soong J.C., Lufkin R.B., et al. Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-d-glucose and MR imaging correlation. Radiology 186 (1993) 27-35
38. Rahn A.N., Baum R.P., Adamietz I.A., Adams S., Sengupta S., Mose S., et al. Value of 18F fluorodeoxyglucose positron emission tomography in radiotherapy planning of head-neck tumors. Strahlenther Onkol 174 (1998) 358-364